Palvella Therapeutics (PVLA) EBITDA Margin Growth (5y) (2019 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -504,068.00 |
| Sep 30, 2023 | 911.00 |
| Jun 30, 2023 | -607.00 |
| Mar 31, 2023 | -44,917.00 |
| Sep 30, 2022 | -362,298.00 |
| Jun 30, 2022 | 27,134.00 |
| Mar 31, 2022 | 54,614.00 |
| Dec 31, 2021 | 4,722.00 |
| Sep 30, 2021 | 20,654.00 |
| Jun 30, 2021 | -6,840.00 |
| Mar 31, 2021 | 32,307.00 |
| Dec 31, 2020 | -134,732.00 |
| Sep 30, 2020 | 45,940.00 |
| Jun 30, 2020 | 216,309.00 |
| Mar 31, 2020 | 167,948.00 |
| Sep 30, 2019 | 982,895.00 |
| Jun 30, 2019 | 16,398.00 |